Edition:
United States

Philip Morris International Inc (PM.N)

PM.N on New York Stock Exchange

104.31USD
16 Feb 2018
Change (% chg)

$0.62 (+0.60%)
Prev Close
$103.69
Open
$103.44
Day's High
$105.13
Day's Low
$103.05
Volume
2,158,563
Avg. Vol
1,353,613
52-wk High
$123.53
52-wk Low
$96.67

Chart for

About

Philip Morris International Inc. is a holding company. The Company is engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States. Its segments include European Union (EU); Eastern Europe, Middle East & Africa (EEMA); Asia, and Latin... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $162,014.59
Shares Outstanding(Mil.): 1,553.20
Dividend: 1.07
Yield (%): 4.13

Financials

  Industry Sector
P/E (TTM): -- 39.05 17.27
EPS (TTM): -- -- --
ROI: -- 35.98 35.43
ROE: -- 38.07 17.10

BRIEF-Philip Morris International Sees Q1 Reported Earnings Per Share $0.87

* PHILIP MORRIS INTERNATIONAL INC - SEES STRONG NET ‍​REVENUE GROWTH EX-CURRENCY FOR Q1 2018

Feb 08 2018

BRIEF-Philip Morris International Reports Qtrly Adj EPS Of $1.31

* PHILIP MORRIS INTERNATIONAL INC. PHILIP MORRIS INTERNATIONAL INC. (PMI) REPORTS 2017 RESULTS; EXCLUDING CURRENCY & TAX ITEMS, FULL-YEAR 2017 ADJUSTED DILUTED EPS GROWTH OF 10%; PROVIDES 2018 EARNINGS PER SHARE FORECAST

Feb 08 2018

U.S. senators ask FDA to reject Philip Morris' iQOS application

WASHINGTON/NEW DELHI Ten U.S. senators called on the Food and Drug Administration to reject Philip Morris International Inc's application to market its iQOS smoking device as being less risky than cigarettes, according to a letter to the agency's commissioner.

Feb 07 2018

UPDATE 1-U.S. senators ask FDA to reject Philip Morris' iQOS application

WASHINGTON/NEW DELHI, Feb 7 Ten U.S. senators called on the Food and Drug Administration to reject Philip Morris International Inc's application to market its iQOS smoking device as being less risky than cigarettes, according to a letter to the agency's commissioner.

Feb 07 2018

Paritosh Bansal appointed Americas managing editor for news

In a memo to staff on Wednesday, Reuters Americas Regional Editor Tiffany Wu announced the appointment of Paritosh Bansal as Americas Managing Editor for News. Read more below:

Feb 07 2018

U.S. lawmakers ask FDA to reject Philip Morris' iQOS application

WASHINGTON/NEW DELHI, Feb 7 Ten U.S. senators called on the Food and Drug Administration to reject Philip Morris International Inc's application to market its iQOS smoking device as being less risky than cigarettes, according to a letter to the agency's commissioner.

Feb 07 2018

Japan Tobacco to launch new smokeless product this year

TOKYO Japan Tobacco Inc said on Tuesday it plans to launch a new "heat-not-burn" (HNB) product in Japan as early as the end of this year, as it tries to catch Philip Morris International in a growing cigarette-alternative category.

Feb 06 2018

UPDATE 1-Japan Tobacco to launch new smokeless product this year

* Heat-not-burn cigarette alternatives are very popular in Japan

Feb 06 2018

Japan Tobacco to launch new smokeless product this year

TOKYO, Feb 6 Japan Tobacco Inc said on Tuesday it plans to launch a new "heat-not-burn" (HNB) product in Japan as early as the end of this year, as it tries to catch Philip Morris International in a growing cigarette-alternative category.

Feb 06 2018

Two U.S. lawmakers voice concerns over Philip Morris tobacco trials

WASHINGTON Two Democratic U.S. senators said they have fresh concerns over clinical trials conducted by Philip Morris International Inc as it seeks U.S. clearance to market its iQOS electronic tobacco product as less risky than cigarettes, according to statements both senators provided to Reuters.

Feb 01 2018

Earnings vs. Estimates